Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-24-003170
Filing Date
2024-02-13
Accepted
2024-02-13 16:16:06
Documents
1
Period of Report
2024-02-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7440
  Complete submission text file 0001209191-24-003170.txt   8829
Mailing Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302
Business Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302 551-430-6000
Organon & Co. (Issuer) CIK: 0001821825 (see all company filings)

EIN.: 464838035 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 30 HUDSON STREET, FLOOR 33 JERSEY CITY NJ 07302
Business Address
DiMarco Kathryn (Reporting) CIK: 0001861045 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40235 | Film No.: 24626135